Is pharma willing to disrupt itself? What does disruption look like in pharma? If a change is good for everyone, is it really disruptive? These and other questions were explored during the 2 day Disruptive Innovations to Advance Clinical Trials Conference in Boston last month.
See on portal.lillycoi.com